| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |